Studies on the risk factors for fenofibrate-induced elevation of liver function tests

Yakugaku Zasshi

Volumn 122, Issue 2, 2002, Pages 169-175

  Hayakawa, Toru ^a,b   Hayashi, Akemi ^a   Miyakawa, Maiko ^a   Shimoyama, Koichi ^a   Sekiya, Shigeru ^a   Sekiguchi, Masatomo ^a   Inotsume, Nobuo ^b  

^a Sapporo Kosei General Hospital   (Japan)

^b HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Fenofibrate; Hyperlipidemia; Liver function tests; Risk factor

Indexed keywords

FENOFIBRATE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); TRIACYLGLYCEROL; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENT; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; FEMALE; HUMAN; HYPERLIPIDEMIA; LABORATORY DIAGNOSIS; LABORATORY TEST; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LOGISTIC REGRESSION ANALYSIS; MALE; PHYSICAL EXAMINATION; RISK FACTOR; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHEMICALLY INDUCED DISORDER; LIVER DISEASE; MIDDLE AGED; SEX DIFFERENCE; STATISTICAL MODEL;

AGED; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENTS; BODY MASS INDEX; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROCETOFEN; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 0036483083     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.122.169     Document Type: Article

References (17)

1. Blane G. F., Cardiology., 71, 1-13 (1989).
2. Itakura H., Goto Y., Yasugi T., Hata Y., Nakaya N., Saito Y., Tsushima M., Prog. Med., 17, 635-659 (1997).
3. Goto Y., Saito Y., Itakura H., Hata Y., Nakaya N., Mabuchi H., Nakai T., Hidaka H., Kita T., Matsuzawa Y., Tsushima M., Geriatr. Med., 33, 909-938 (1995).
4. Brown W. V., Dujovne C. A., Farquhar J. W., Feldman E. B., Arteriosclerosis, 6, 670-678 (1986).
5. Edger A. D., Tomkiewicz C., Costet P., Legendre C., Aggerbeck M., Bouguet J., Staels B., Guyomard C., Pineau T., Barouki R., Toxicol. Lett., 98, 13-23 (1998).
6. Fitsher B. A., Klaassen-Schluter C. M., Stremmel W., Biochim. Biophys. Acta., 1256, 47-51 (1995).
7. Yu K., Bayona W., Kallen C. B., Harding H. P., Ravera C. P., McMahon G., Brown M., Lazer M. A., J. Biol. Chem., 270, 23975-23983 (1995).
8. Martin P. J., Martin J., Goldberg D. M., Br. Med. J., 1, 17-18 (1975).
9. Hukuo Y., Kitami S., Nomoto T., Kaku A., J. Adult. Dis., 7, 893-899 (1996).
10. Ono T., Kido Y., Jpn. Pharmacol. Ther., 9, 397-406 (1981).
11. Mogi M., Jpn. Pharmacol. Ther., 23, 1117-1133 (1995).
12. Steinmetz J., Marin C., Panek E., Siest G., Drouin P., Clin. Chim. Acta, 112, 43-53 (1981).
13. Henze K., Wallmuller-Strycker A., Bauer M., Barth C., Wolfram G., Zollner N., J. Clin. Chem. Biochem., 19, 1013-1019 (1981).
14. Olefsky J., Farguhar J. W., Reaven G. H., Eur. J. Clin. Invest., 4, 121-127 (1974).
15. Wahl P. W., Walden C. E., Knupp R. H., Warnick G. R., Hoover J. J., Hazzard W. R., Albers J. J., Metabolism, 33, 502-508 (1984).
16. Kral J. G., Lundholm K., Bjorntorp P., Sjostrom L., Schersten T., Metabolism, 26, 1025-1031 (1977).
17. Nakaya N., Hukuhara H., Mogi M., Jpn. Pharmacol. Ther., 23, 1617-1626 (1995).